Lotte van Andel

5PUBLICATIONS
4CO-AUTHORS
BiomaterialsPharmacogenomicsToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 22, 2025
Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans.

Jean-Yves Gillon, François Simon, Sharan Sidhu

|Jul 26, 2018
Review of Chromatographic Bioanalytical Assays for the Quantitative Determination of Marine-Derived Drugs for Cancer Treatment.

Lotte van Andel, Hilde Rosing, Jan Hm Schellens

|Jul 06, 2018
Metabolite profiling of the novel anti-cancer agent, plitidepsin, in urine and faeces in cancer patients after administration of <sup>14</sup>C-plitidepsin.

L van Andel, H Rosing, M M Tibben

|Nov 29, 2017
Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a <sup>14</sup>C-microtracer and therapeutic dose in cancer patients.

L van Andel, H Rosing, Z Zhang

|Oct 19, 2017
Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a <sup>14</sup>C-microtracer and therapeutic dose in cancer patients.

L van Andel, H Rosing, Z Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Jean-Yves Gillon

1 joint publications

François Simon

1 joint publications

Delphine Launay

1 joint publications

Antoine Tarral